ZIMMER BIOMET HLDGS DL-01
ZIMMER BIOMET HLDGS DL-01/ US98956P1021 /
ZIM
6/7/2024 9:44:25 PM
|
Chg.
+0.800
|
Volume |
Bid9:59:57 PM |
Ask9:59:57 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
104.700EUR
|
+0.77%
|
7 Turnover: 728.850 |
104.750Bid Size: 95 |
105.150Ask Size: 95 |
21.59 bill.EUR |
- |
- |
Fundamentals
|
FY 2023 |
Growth (1Y) |
Per Share |
|
Earnings per Share: |
4.91 USD |
346.36% |
EPS Diluted: |
4.88 USD |
343.64% |
Revenues per Share: |
36.05 USD |
8.57% |
Book Value per Share: |
60.89 USD |
5.81% |
Cash Flow per Share: |
7.71 USD |
18.84% |
Dividend per Share: |
0.96 USD |
0.00% |
Total |
in mill. |
|
Revenues: |
7,394.20 USD |
6.55% |
Net Income: |
1,024.00 USD |
342.52% |
Operating Cash Flow: |
1,581.60 USD |
- |
Cash and Cash Equivalents: |
415.80 USD |
- |
Valuation Ratios
|
Current |
Latest FY* |
P/E Ratio: |
23.08 |
24.79 |
P/S Ratio: |
3.14 |
3.38 |
P/BV ratio: |
1.86 |
2.00 |
P/CF Ratio: |
14.70 |
15.78 |
PEG: |
0.07 |
0.07 |
Earnings Yield: |
4.33% |
4.03% |
Dividend Yield: |
0.85% |
0.79% |
Market Capitalization |
|
Market Capitalization: |
21.59 bill. EUR |
22.61 bill. EUR |
Free Float Market Cap.: |
- EUR |
- EUR |
Market Cap. / Employee: |
- EUR |
- EUR |
Shares Outstanding: |
205.73 mill. |
|
Profitability
Gross Profit Margin: |
71.82% |
EBIT Margin: |
17.28% |
Net Profit Margin: |
13.85% |
Return on Equity: |
8.20% |
Return on Assets: |
4.76% |
Financial Strength
Liquidity I / Cash Ratio: |
14.55% |
Liquidity II / Quick Ratio: |
65.03% |
Liquidity III / Current Ratio: |
161.32% |
Debt / Equity Ratio: |
72.14% |
Dynam. Debt / Equity Ratio: |
569.60% |
Efficiency
Employees: |
- |
Personal Expenses / Employee: |
- USD |
Revenues / Employee: |
- USD |
Net Income / Employee: |
- USD |
Total Assets / Employee: |
- USD |
* Fiscal Year End: |
12/31/2023 |
Accounting Standard: |
US GAAP |